Hanneke W. Wilmink

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Response letter 'A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer'.

Response letter 'A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer'.

Journal: BJU international

Published: June 09, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2026

Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA): Study Protocol for a Pan-European Prospective Multicenter Double Single Arm Trial.

Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA): Study Protocol for a Pan-European Prospective Multicenter Double Single Arm Trial.

Journal: American journal of clinical oncology

Published: March 11, 2026

Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis.

Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: September 16, 2025

Impact of Merging two high-volume Centers on Patient Outcome: 1000 Consecutive Pancreatoduodenectomies.

Impact of Merging two high-volume Centers on Patient Outcome: 1000 Consecutive Pancreatoduodenectomies.

Journal: Annals of surgery

Published: June 02, 2025

A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer.

A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer.

Journal: BJU international

Published: May 22, 2025

The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN).

The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN).

Journal: United European gastroenterology journal

Published: February 02, 2025

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.

Journal: Current opinion in hematology

Published: January 24, 2025

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial.

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial.

Journal: BMC cancer

Published: January 12, 2025

Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary region.

Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary region.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 16, 2024

Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma.

Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma.

Journal: Thrombosis research

Published: March 14, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026